Comment Sought on Cancer Trials Database

The National Institutes of Health on Jan. 29 opened a 30-day comment period on the National Cancer Institute’s Clinical Trials Reporting Program Database, now under development.


The National Institutes of Health on Jan. 29 opened a 30-day comment period on the National Cancer Institute's Clinical Trials Reporting Program Database, now under development.

NIH previously held a 60-day comment period and received only two comments from a single individual.

The National Cancer Institute views the database "as a single, definitive source of information about all NCI-supported clinical research, thereby enabling the NCI to execute its mission to reduce the burden of cancer and to ensure an optimal return on the nation's investment in cancer clinical research," according to a notice published Jan. 29 in the Federal Register. "Information will be submitted by clinical research administrators as designees of clinical investigators who conduct NCI-supported clinical research. Deployment and extension of the CTRP Database, which will allow the NCI to consolidate reporting, aggregate information and reduce redundant submissions, is an infrastructure development project that will be enabled by public funds expended pursuant to the American Recovery and Reinvestment Act."

The notice is available at gpoaccess.gov/fr/index.html.

--Joseph Goedert

More for you

Loading data for hdm_tax_topic #better-outcomes...